Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500112024Phase 4Completed
Phase 4, open-label trial of propofol in pulmonary tuberculosis (TB) (2 arms), sponsored by The Second Hospital of Nanjing. Primary endpoints: Major postoperative discomfort symptoms, Other postoperative discomfort symptoms and 1 more. Started Nov 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500112024.